Cytek Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Cytek Biosciences

12/05/2022 18:16

* Cytek Biosciences Inc  CTKB.OQ  reported quarterly
adjusted
earnings of 1 cent​​ per share for the quarter ended in March.
The mean expectation of four analysts for the quarter was
for breakeven results per share.
    * Revenue was $35.06 million​;  analysts expected $32.51
million. 
    * Cytek Biosciences Inc's reported EPS for the quarter was a
loss
of 2 cents​.
    * The mean earnings estimate of analysts had fallen by
about 140%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Cytek Biosciences Inc shares had fallen by 31.3% this
quarter and lost 54.6% so far this year.
    * The company reported a quarterly loss of $2.02 million.
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 05:15 p.m.  ​All
figures in US dollars unless otherwise stated